D-Ribose for Fatigue in Subjects With Fibromyalgia
Completed · Phase 2 · Has a placebo group
Conditions studied: Fibromyalgia
In brief
To evaluate the safety and to determine the efficacy of D-ribose for the amelioration of fatigue in subjects with fibromyalgia. This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center, multiple dose study of D-ribose versus placebo administered at doses of 5 g three times a day (TID) over a 12-week period to subjects who are experiencing fatigue associated with a diagnosis of fibromyalgia.
Key facts
- Study ID
- NCT01315210
- Run by
- RiboCor, Inc.
- People needed
- 110
- Starts
- 2011-05-01
- Expected to finish
- 2012-10-01
- Last updated by the study team
- 2013-09-18
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Superior Research, LLC — Sacramento, California, United States
- Avail Clinical Research — DeLand, Florida, United States
- Renstar Medical Research — Ocala, Florida, United States
- University of Kentucky — Lexington, Kentucky, United States
- Columbia Medical Practice — Columbia, Maryland, United States
- The Center for Rheumatology and Bone Research — Wheaton, Maryland, United States
- Peters Medical Research — High Point, North Carolina, United States
- Wake Research Associates, LLC — Raleigh, North Carolina, United States
- Altoona Center for Clinical Research — Duncansville, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.